| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 8.8 | 6.6 | 7.8 |
| Other income | 0.3 | 0.1 | 0.2 |
| Total income | 9.1 | 6.7 | 8.0 |
| Profit before exceptional items & tax | 0.4 | -0.5 | 0.5 |
| Profit before tax | 0.4 | -0.5 | 0.5 |
| Net profit | 0.3 | -0.4 | 0.4 |
| Operating margin | 4.4% | -7.5% | 6.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -25.00% |
|---|---|
| Revenue, year on year | +12.80% |
| Operating profit, year on year | -66.70% |
| Operating profit, quarter on quarter | +116.70% |
BSE results filing, NSE: LINKPH. Figures extracted from the filing.
Link Pharma Chem Ltd: key numbers
- Share price
- ₹25.65
- Market cap
- ₹11.39 Cr
- Revenue (annual)
- ₹27.43 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- -1752.0×Sector 37.2×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Link Pharma Chem Ltd
All →Link Pharma Chem Management Change
Link Pharma Chem Limited has announced the re-appointment of Rishikesh Thakur and Satish G Thakur as Executive Directors for a term of 36 months each.
Link Pharma Chem Annual General Meeting
Link Pharma Chem Ltd. held its 41st Annual General Meeting on August 20, 2026, where shareholders transacted various ordinary and special business items.
Link Pharma Chem Other Announcement
Link Pharma Chem Ltd notified the exchange regarding the dispatch of letters to shareholders containing the web link for the Annual Report 2025-2026.
Link Pharma Chem Board Meeting Date
Link Pharma Chem Ltd has scheduled a board meeting for August 5, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Link Pharma Chem Annual General Meeting
Link Pharma Chem Ltd has issued a notice convening its 41st Annual General Meeting on August 20, 2026, to be held via video conferencing.
Link Pharma Chem Promoter Buying (Off-Market)
Link Pharma Chem disclosed an inter-se transfer of 92,808 shares among promoter group members due to family succession in its shareholding pattern filing.